Bettina Hamelin's lobbying: the registrations they file and every meeting they've reported since November 2021.
← LobbyingRegistrant (responsible officer)
President and CEO
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Former public office
Free trade agreements as they relate to the biopharmaceutical industry
Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products
Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry
Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals
Proposed pharmacare legislation related to any future national pharmacare program
Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry
Proposed pharmacare legislation related to any future national pharmacare program
Establish accountability with the federally financed Canadian Agency for Drugs and Technologies in Health (CADTH)
Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
Foreign AffairsHealthInfrastructureInternational TradeResearch and DevelopmentScience and TechnologySmall BusinessTaxation and Finance
Constitutional IssuesConsumer IssuesFederal-Provincial RelationsForeign AffairsHealthInfrastructureIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologySmall BusinessTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIndustryIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologySmall BusinessTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
AgricultureConsumer IssuesFederal-Provincial RelationsHealthInfrastructureIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Consumer IssuesFederal-Provincial RelationsForeign AffairsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Constitutional IssuesConsumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Constitutional IssuesConsumer IssuesFederal-Provincial RelationsHealthIndustryIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologySmall BusinessTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
Consumer IssuesFederal-Provincial RelationsHealthIntellectual PropertyInternational TradeResearch and DevelopmentScience and TechnologyTaxation and Finance
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.